Leasing of an immunohistochemical analyzer for 5 years with IHC reagents

Leasing of a fully automatic, free-standing immunohistochemical analyzer for the Pathology Department, contract duration 5 years: device for immunohistochemical examination and in situ hybridization, including slide label printer; automated functions such as drying of sections, deparaffinization of tissue, antigen unmasking, cell conditioning, dispensing of detection and staining reagents, counterstaining; night operation without supervision; capacity of at least 90 slides per 24 hours; at least 30 positions for preparations and 30 positions for antibodies and detection systems; open system for antibodies from various manufacturers; homogeneous staining; operating reagents free of organic solvents; PC connection; integration into a digitalization system (LIS: LIAPathology); control of reagent quantities and available tests; waste volume monitoring and overflow protection; large-volume reservoirs for reagents and waste; user interface and software in Slovak or Czech; delivery of operating manual (Slovak/Czech), declaration of conformity, application and service support; online service; service technician available within 48 hours; reagent delivery within a maximum of 7 working days; transport and installation; professional training; annual preventive check; software and database updates as needed; application support as needed; free service including transport and spare parts for the entire contract duration. Basic reagents for 31,000 tests: EnVision™ FLEX, High pH; EnVision™ FLEX Target Retrieval Solution, Low pH (50x) (Dako Omnis); Dako Omnis Mixing Strip Wash Buffer (20x) (Dako Omnis); Hematoxylin (Dako Omnis); Sulfuric Acid, 0.3 M, cleaning; Reag Clearify Cleaning Agent; Seymour Label Kit for 3,000 Labels. Consumables: Dako Omnis Small Vial, 2 mL (200 pcs); Dako Omnis Large Vial, 30 mL (380 pcs); EnVision™ FLEX+ Rabbit LINKER (50 pcs); EnVision™ FLEX+ Mouse LINKER (120 pcs); EnVision FLEX DAB Enhancer (10 pcs); PD-L1 control slides (20 pcs); Antibody diluent with Background (35 pcs). Antibodies (number of tests): bcl -2 (124) 120; BAP1 (C-4) 120; bcl-6 (PG-B6p) 120; BSAP (DAK-Pax5) 350; Calretinin (DAK- CD10) 180; CD10 (DAK CD10) 240; CD117 (YR145) 100; CD138 (EP201) 60; CD15 (Carb-3) 80; CD1a (O10) 60; CD20 cy (L26) 300; CD23 (DAK-CD23) 240; CD3 270; CD30 (Ber-H2) 210; CD34 (QBEnd 10) 160; CD43 (DF-T1) 120; CD45 LCA (2B11+PD7/26) 240; CD5 (4CT) 240; CD56 (123C3) 120; CD68 (Kp-1) 120; CD79 a (JCB117) 120; CD99 (12E7) 60; CDX2 (DAK-CD23) 1,200; CEA 60; CK- pan (AE1/3) 1,000; CK20 ( Ks20.8) 800; CK5/6 (D4/16 B4) 200; CK7 (O-TL 12/30) 2,100; CK8/18 60; Cyclin D1, (EP12) 320; Desmin (D33) 80; EBV (CS.1-4) 60; E-cadherin (NCH-38) 1,000; EMA ( E29) 60; ER (clone EP1) 600; ERG (EP111) 60; FLI-1 60; GATA3 (L50-823) 800; Helicobacter Pylori 120; HMB45 (HMB-45) 120; Chromogranin A (DAK-A3) 600; INSM1 (BSB-123) 1,200; Kappa (ZM81) 120; Ki-67 (MIB-1) 1,600; Lambda (BSB-16) 120; MAML 120; Melan A (MART-1 A103) 160; MUM1 (MUM1p) 80; Napsin A (MRQ-60) 1,800; NeuroD1 120; NKX3.1 (EP356) 280; NSE (BBS/NC/VI-H14) 60; NUT 120; p16 (R15A) 360; p40 (DAK-p40) 3,000; p53 (DO-7) 60; PAX-8 (ZR1) 700; PD-L1 (22C3) 2,000; PHH3 (ZR285) 240; PLAP (8A9) 60; Podoplanin (D2-40) 60; POUF2F3 120; PR (Clone PgR 1294) 600; PTH (OP-4) 60; S100 240; SALL4 (6E3) 60; SMA (1A4) 200; SMARCA4 120; SOX10 (BC34) 300; SS18 SSX (RBT-SS18-SSX) 100; STAT6 (EP325) 120; Synaptophysin (DAK SYNAP) 1,000; TdT (EP266) 120; Thyroglobulin (polyclonal) 60; TTF-1 (8G763/1) 4,700; Vimentin (V9) 500; WT1 (6-H2) 400. Equivalent offers are permitted.

Tender documents

Additional details